title: Endocrine function after bone marrow transplantation for thalassemia.
authors.affiliation: Divisione di Ematologia, Ospedale di Pesaro, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Galimberti
authors.forename: V
authors.initials: V
authors.lastname: De Sanctis
authors.forename: G
authors.initials: G
authors.lastname: Lucarelli
authors.forename: P
authors.initials: P
authors.lastname: Polchi
authors.forename: E
authors.initials: E
authors.lastname: Angelucci
authors.forename: D
authors.initials: D
authors.lastname: Baronciani
authors.forename: C
authors.initials: C
authors.lastname: Vullo
authors.forename: B
authors.initials: B
authors.lastname: Bagni
mesh_terms: D000293:Adolescent; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods / Q000502:physiology; D002066:Busulfan / Q000009:adverse effects*; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects*; D004700:Endocrine System Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D011184:Postoperative Period; D011628:Puberty, Delayed / Q000139:chemically induced; D011788:Quality of Life; D013789:Thalassemia / Q000503:physiopathology / Q000601:surgery*
chemical_list: D003520:Cyclophosphamide; D002066:Busulfan